(Q44440538)

English

Control of Insulin-Like Growth Factor Binding Protein-5 Protease Synthesis and Secretion by Human Fibroblasts and Porcine Aortic Smooth Muscle Cells

scientific article published on June 1, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

Control of insulin-like growth factor binding protein-5 protease synthesis and secretion by human fibroblasts and porcine aortic smooth muscle cells (English)

1 reference

Europe PubMed Central

3 December 2017

Control of Insulin-Like Growth Factor Binding Protein-5 Protease Synthesis and Secretion by Human Fibroblasts and Porcine Aortic Smooth Muscle Cells (English)

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

author name string

Anna Moralez

1

1 reference

Europe PubMed Central

3 December 2017

David Clemmons

3

1 reference

Europe PubMed Central

3 December 2017

Walker H. Busby

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12746311

2 January 2024

language of work or name

0 references

publication date

1 June 2003

1 reference

Europe PubMed Central

3 December 2017

full work available at URL

http://academic.oup.com/endo/article-pdf/144/6/2489/9302644/endo2489.pdf

Portable Document Format

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

1 reference

Europe PubMed Central

3 December 2017

144

1 reference

Europe PubMed Central

3 December 2017

2489-2495

1 reference

Europe PubMed Central

3 December 2017

6

1 reference

Europe PubMed Central

3 December 2017

RETRACTED: A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1073/PNAS.96.17.9879

Extracellular matrix contains insulin-like growth factor binding protein-5: potentiation of the effects of IGF-I.

3

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5.

4

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Substitutions for hydrophobic amino acids in the N-terminal domains of IGFBP-3 and -5 markedly reduce IGF-I binding and alter their biologic actions

5

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Protease-resistant form of insulin-like growth factor-binding protein 5 is an inhibitor of insulin-like growth factor-I actions on porcine smooth muscle cells in culture.

6

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I

7

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor-binding protein-5 in fibroblast medium

8

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Variables controlling somatomedin production by cultured human fibroblasts

9

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

A factor contained in plasma is required for IGF binding protein-1 to potentiate the effect of IGF-I on smooth muscle cell DNA synthesis

10

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Human complement component C1s. Partial sequence determination of the heavy chain and identification of the peptide bond cleaved during activation

11

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Synovial fibroblast-like cells synthesize seven proteins of the complement system

12

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Complement components C1q, C1r/C1s, and C1INH in rheumatoid arthritis. Correlation of in situ hybridization and northern blot results with function and protein concentration in synovium and primary cell cultures

16

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Biosynthesis of the subcomponents C1q, C1r and C1s of the first component of complement (C1) by guinea pig hepatocyte primary cultures

17

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Molecular cloning of a cDNA encoding a serine protease homologous to complement C1s precursor from rat C6 glial cells and its expression during glial differentiation

18

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Complement classical pathway expression by human skeletal myoblasts in vitro

19

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.

20

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Inhibition of insulin-like growth factor binding protein 5 proteolysis in articular cartilage and joint fluid results in enhanced concentrations of insulin-like growth factor 1 and is associated with improved osteoarthritis

21

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Evidence that IGF-binding protein-5 functions as a growth factor

22

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Insulin-like growth factor I protects oligodendrocytes from tumor necrosis factor-alpha-induced injury

24

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Insulin-like growth factor-I stimulates dephosphorylation of ikappa B through the serine phosphatase calcineurin (protein phosphatase 2B)

26

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha

27

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Genetic enhancement of matrix synthesis by articular chondrocytes: comparison of different growth factor genes in the presence and absence of interleukin-1.

28

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Cytokine regulation of cartilage-derived retinoic acid-sensitive protein (CD-RAP) in primary articular chondrocytes: suppression by IL-1, bfGF, TGFbeta and stimulation by IGF-1.

30

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Chondrocyte phenotype and cell survival are regulated by culture conditions and by specific cytokines through the expression of Sox-9 transcription factor.

31

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Tissue-specific regulation of IGF-I and IGF-binding proteins in response to TNFalpha

32

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Inhibition of osteoblast differentiation by tumor necrosis factor-alpha

33

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Tumor Necrosis Factor-α Regulates Insulin-Like Growth Factor-1 and Insulin-Like Growth Factor Binding Protein-3 Expression in Vascular Smooth Muscle

34

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture

36

1 reference

10.1210/EN.2002-220896

https://api.crossref.org/works/10.1210/EN.2002-220896

2 January 2024

Identifiers

10.1210/EN.2002-220896

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44440538&oldid=2043144975"